A carregar...
Development and validation of a rapid HPLC method for quantitation of SP-141, a novel pyrido[b]indole anticancer agent, and an initial pharmacokinetic study in mice
There is an increasing interest in targeting the MDM2 oncogene for cancer therapy. SP-141, a novel designed small molecule MDM2 inhibitor, exerts excellent in vitro and in vivo anticancer activity. To facilitate the preclinical development of this candidate anticancer agent, we have developed an HPL...
Na minha lista:
| Publicado no: | Biomed Chromatogr |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4710169/ https://ncbi.nlm.nih.gov/pubmed/25294254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bmc.3327 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|